| Article | Date | Source |
|---|
| Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia??? | May 04, 2012 | BioSpace - Breaking News |
| Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™ | May 04, 2012 | Pharma News - Business Wire |
| Accentia Biopharmaceuticals Completes Sale of Analytica Subsidiary | December 20, 2011 | Pharma News - Business Wire |
| ACCENTIA BIOPHARMACEUTICALS INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | December 19, 2011 | Biotechnology - Moreover |
| Accentia Biopharmaceuticals Has $10 Million Deal to Sell | November 07, 2011 | BioSpace |
| Accentia has $10 million deal to sell Analytica | November 07, 2011 | Health News - BizJournals.com |
| Accentia Biopharmaceuticals Announces Series of Agreements as Part of Debt Reduction Strategy to Strengthen Financial Condition, Improve Balance Sheet and Support Advancement of Immunotherapy Pipeline | November 07, 2011 | Pharma News - Business Wire |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant | September 14, 2011 | BioSpace - Breaking News |
| Accentia drug gets FDA OK | September 14, 2011 | Health News - BizJournals.com |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune™ Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant | September 14, 2011 | FDA News - Business Wire |
| Accentia and Biovest to Present at BIO International Convention | June 24, 2011 | Biotech News - Business Wire |
| Accentia Biopharmaceuticals Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia | June 23, 2011 | BioSpace - Breaking News |
| Accentia drug Revimmune receives FDA designation | June 23, 2011 | Health News - BizJournals.com |
| Accentia Biopharmaceuticals Announces that FDA grants Orphan Drug Status for Revimmune™ Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia | June 23, 2011 | FDA News - Business Wire |
| Accentia gets $4 million for development | June 14, 2011 | Health News - BizJournals.com |
| Accentia Biopharmaceuticals Announces Key Additions to its Scientific Advisory Board to Advance Revimmune™ for the Treatment of Autoimmune Diseases including Multiple Sclerosis | June 02, 2011 | Pharma News - Business Wire |
| Accentia Biopharmaceuticals Announces that Revimmune™ Autoimmune Disease Therapy is Featured in Peer-review Journal | May 04, 2011 | Pharma News - Business Wire |
| Accentia looks to raise $5M in offering | February 22, 2011 | Health News - BizJournals.com |
| Accentia Biopharmaceuticals looks to raise $5 million in offering | February 22, 2011 | Health News - BizJournals.com |
| Accentia inks stretagic alliance with Baxter to acquire cyclophosphamide | November 30, 2010 | Pharmaceutical - Moreover |
| Accentia Secures Rights to Baxter’s Cyclophosphamide for Autoimmune Candidate | November 29, 2010 | Inside Industry - Gen |
| Accentia Biopharmaceuticals Announces Strategic Agreement with Baxter | November 29, 2010 | Pharma News - Business Wire |
| Accentia Biopharmaceuticals, Biovest International, Inc. Emerges from Chapter 11 Reorganization | November 17, 2010 | BioSpace |
| Accentia Biopharmaceuticals, Biovest International, Inc. Announces Confirmation of Plan of Reorganization As It Emerges From Chapter 11 | October 28, 2010 | BioSpace |
| Accentia Announces Confirmation of Plan of Reorganization | October 28, 2010 | Pharma News - Business Wire |
| Accentia files reorganization plan | June 01, 2010 | FierceBiotech |
| Accentia Files Plan of Reorganization | June 01, 2010 | Pharma News - Business Wire |
